1097 related articles for article (PubMed ID: 28280249)
21. Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.
Kemball CC; Lee ED; Szomolanyi-Tsuda E; Pearson TC; Larsen CP; Lukacher AE
J Immunol; 2006 Feb; 176(3):1814-24. PubMed ID: 16424212
[TBL] [Abstract][Full Text] [Related]
22. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
Behar SM; Porcelli SA; Beckman EM; Brenner MB
J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
[TBL] [Abstract][Full Text] [Related]
23. Interrupting CD28 costimulation before antigen rechallenge affects CD8(+) T-cell expansion and effector functions during secondary response in mice.
Fröhlich M; Gogishvili T; Langenhorst D; Lühder F; Hünig T
Eur J Immunol; 2016 Jul; 46(7):1644-55. PubMed ID: 27122236
[TBL] [Abstract][Full Text] [Related]
24. PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways.
Zhao Y; Lee CK; Lin CH; Gassen RB; Xu X; Huang Z; Xiao C; Bonorino C; Lu LF; Bui JD; Hui E
Immunity; 2019 Dec; 51(6):1059-1073.e9. PubMed ID: 31757674
[TBL] [Abstract][Full Text] [Related]
25. CD28 days later: Resurrecting costimulation for CD8(+) memory T cells.
van der Heide V; Homann D
Eur J Immunol; 2016 Jul; 46(7):1587-91. PubMed ID: 27401871
[TBL] [Abstract][Full Text] [Related]
26. Restriction of PD-1 function by
Sugiura D; Maruhashi T; Okazaki IM; Shimizu K; Maeda TK; Takemoto T; Okazaki T
Science; 2019 May; 364(6440):558-566. PubMed ID: 31000591
[TBL] [Abstract][Full Text] [Related]
27. Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1
Humblin E; Korpas I; Lu J; Filipescu D; van der Heide V; Goldstein S; Vaidya A; Soares-Schanoski A; Casati B; Selvan ME; Gümüş ZH; Wieland A; Corrado M; Cohen-Gould L; Bernstein E; Homann D; Chipuk J; Kamphorst AO
Sci Immunol; 2023 Aug; 8(86):eadg0878. PubMed ID: 37624910
[TBL] [Abstract][Full Text] [Related]
28. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.
Wu Y; Guo Y; Huang A; Zheng P; Liu Y
J Exp Med; 1997 Apr; 185(7):1327-35. PubMed ID: 9104819
[TBL] [Abstract][Full Text] [Related]
29. TLR4 signaling improves PD-1 blockade therapy during chronic viral infection.
Wang Y; Chung YR; Eitzinger S; Palacio N; Gregory S; Bhattacharyya M; Penaloza-MacMaster P
PLoS Pathog; 2019 Feb; 15(2):e1007583. PubMed ID: 30726291
[TBL] [Abstract][Full Text] [Related]
30. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
31. Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes.
Keir ME; Latchman YE; Freeman GJ; Sharpe AH
J Immunol; 2005 Dec; 175(11):7372-9. PubMed ID: 16301644
[TBL] [Abstract][Full Text] [Related]
32. The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus.
Grujic M; Bartholdy C; Remy M; Pinschewer DD; Christensen JP; Thomsen AR
J Immunol; 2010 Aug; 185(3):1730-43. PubMed ID: 20601595
[TBL] [Abstract][Full Text] [Related]
33. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
[TBL] [Abstract][Full Text] [Related]
34. Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling.
Geng CL; Chen JY; Song TY; Jung JH; Long M; Song MF; Ji T; Min BS; Lee JG; Peng B; Pu YS; Fan HJ; Hao P; Zhou Q; Shin EC; Cang Y
Cell Chem Biol; 2022 Aug; 29(8):1260-1272.e8. PubMed ID: 35732177
[TBL] [Abstract][Full Text] [Related]
35. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
[TBL] [Abstract][Full Text] [Related]
36. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
[TBL] [Abstract][Full Text] [Related]
37. The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion.
Hofmeyer KA; Jeon H; Zang X
J Biomed Biotechnol; 2011; 2011():451694. PubMed ID: 21960736
[TBL] [Abstract][Full Text] [Related]
38. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
[TBL] [Abstract][Full Text] [Related]
39. CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells.
Vacchio MS; Hodes RJ
J Exp Med; 2003 Jan; 197(1):19-26. PubMed ID: 12515810
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection.
Garidou L; Heydari S; Truong P; Brooks DG; McGavern DB
J Virol; 2009 Sep; 83(17):8905-15. PubMed ID: 19553326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
